Breast CancerClinical TopicsNewsOncologyOncology Resource CenterWomen's Health

Scientists can silence inflammatory gene responsible for a form of breast cancer

Share
By: Riley Kleemeier

Scientists have found that they are able to “switch off,” or silence, a gene that is responsible for an aggressive form of breast cancer.

Researchers worked with two known breast cancer genes, Rab27a and TRAF31P2, to test the effects of “switching them off.” When the researchers “switched off” the TRAF31P2 gene, they found that this suppressed the growth of the patients’ tumors and prevented metastasis for up to one year. Furthermore, previously existing tumors shrank until undetectable.

The final takeaway from the study concluded that the TRAF3IP2 gene could be targeted in a novel therapeutic approach.

To read more about this study, please click here.

Source: https://www.nature.com/articles/s41598-020-64781-z.epdf?sharing_token=g5pMd4_e6Nk6moKYt8K719RgN0jAjWel9jnR3ZoTv0NqsC8K8p3YcQkhq3pkVMte2MxGIYJilndbyCeof7SHjPMZP5hYcb2EeflxdT2dIdfwhRxJzVCGaDZq4LiDTtpIlqpA9_XIwKptc-BPRuaFkiV58_Sfnm0joShFtH4mRsQ%3D

*Online Bonus Content: This has not been peer reviewed. The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal.

Take the 2024 Nursing Trends and Salary Survey, available now through November 1st 2024

See Past Results
cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

What is the primary purpose of a 3-minute foot assessment in patients with comorbidities such as diabetes or peripheral arterial disease?

More News